- Research article
- Open Access
Characterization of the apical bridge barrier formed following amelogenin apexification
BMC Oral Health volume 18, Article number: 201 (2018)
Recombinant amelogenin protein (RAP) is reported to induce complete root apex formation in dog model when used as apexification therapy. It also induces pulp regeneration in 85% of the treated group. Thus, the aim of this study was to investigate the nature of the remaining regenerated calcified tissues of the RAP group that showed no pulp regeneration compared to the calcium hydroxide treated group (CH).
A total of 240 dogs’ open apex root canals were used, after establishment of canals contamination. Canals were cleaned, irrigated, and filled with RAP as an apexification material and compared with CH. Treated teeth were assessed by H&E, trichrome staining, and/or immunohistochemistry technique, at 1, 3, and 6 months.
A time-dependent increase in the calcified tissue barrier was observed in the apex of the RAP-treated group compared to the CH-treated group. The newly formed dentin in this RAP group was mainly tubular dentin and was functionally attached to the bone by periodontal ligament, while the CH group showed dentin-associated mineralized tissue (DAMT) associated with the newly formed apical barrier.
Out results suggest that RAP can be used as novel apexification material, resulting in a thickening and strengthening of the canal walls, and achieving apical closure.
When teeth with incomplete root formation suffer pulpal necrosis, root development ceases, the canal remains large with thin or fragile walls, and the apex remains open . These features make canals instrumentation and the formation of an adequate apical stop difficult. This requires the placement of an intracanal medicament to stimulate apical healing and formatting an apical barrier (AB) . The commonly accepted medicament for apexification is calcium hydroxide (CH). Although depending on the clinical application, some demonstrated that CH show the least biocompatibility effect when used as a root canal filling material in dog deciduous teeth compared to Maisto (paste) and sealer 26 with iodoform , others show that CH can successfully induce apical closure in young permanent incisors with necrotic teeth and resolve clinical symptoms . However, CH therapy has many disadvantages, including variability of treatment time, unpredictability of apical closure, and patient compliance . In addition, long-term CH therapy has been shown to make teeth brittle . In contrast, mineral trioxide aggregate (MTA) has also been used to provide an artificial barrier. It has the advantage of more predictable outcomes, less treatment time, and relies less on patient compliance. However, MTA still has limitations, including its inability to reinforce the root canal dentin and its high cost . This implicates the need of a new regenerative material that can overcome these biological and technical disadvantages.
Amelogenin is an extracellular matrix protein that regulates the initiation and growth of hydroxyapatite crystals during mineralization of enamel  and also directs the formation of cementum during embryonic root development [9, 10]. Amelogenin splicing isoforms, leucine-rich amelogenin peptide (LRAP), induces osteogenesis in various cell types by activating the canonical Wnt signaling pathway to induce osteogenic differentiation . LRAP treatment induces significant increases in mineral matrix formation and in bone sialoprotein and osterix gene expression. In addition, the impaired osteogenesis of amelogenin-null ES cells is partially rescued by the addition of exogenous LRAP [12, 13].
Recently, the capacity of the recombinant amelogenin protein (rM180) to act as an apexification therapy, to facilitate incomplete root apex formation in a dog model . Amelogenin-treated canals showed calcified tissue formation at the apical foramen that was functionally attached to bone by an oriented periodontal ligament in 89.2% of the specimens . Additionally, this treatment also induced pulp regeneration in 85% of the treated canals. Canals that showed no pulp regeneration still showed thickened root walls covered by an odontoblastic cell layer in addition to the closed apex.
This study investigated the nature of the regenerated calcified tissues of the RAP group that showed no pulp regeneration compared to the no pulp regeneration group treated with calcium hydroxide (CH).
All procedures details were previously mentioned and described by Mounir et al. . In brief, a total of 24 mongrel dogs of 6 months of age were included in this study. Animals were maintained and observed for health assessment before any endodontic procedures were performed.
After anesthetizing animals and pre-operative radiographs confirmed the presence of open apices in the mandibular and maxillary premolars, endodontic access was performed, and pulp tissue was completely removed using H-files. Teeth were managed and left without coronal restoration for 14 days to allow contamination [14, 15]. Animals were then anesthetized using sodium pentobarbital intravenous injection (30 mg/kg body weight); canals were cleaned under aseptic conditions to within 1 mm of the radiographic apices using large H-files in gentile filing movement and 1% sodium hypochlorite was used as an irrigant. After drying the canals with sterile paper points, a cotton pellet was placed in the pulp chamber then sealed with a temporary filling for 7 days (Orafil G, Colostol, Fermin, India). Teeth that showed no signs of infection were included in the study. A total of 240 root canals were divided into two groups: a recombinant amelogenin protein (180 amino acid mouse amelogenin) (RAP) group and the calcium hydroxide-treated (CH) group. An intermediate restorative material (IRM) was then carefully placed over the root canal dressing, and then access cavity was restored with amalgam. After 1, 3, and 6 months postoperatively, the animals were euthanized by intravenous (IV) injection of 20% Pentobarbitone solution, then the samples were evaluated.
Histological procedures and immunohistochemistry protocol
Prepared specimens were stained using hematoxylin and eosin (H&E), trichrome stain, and different immunohistochemical stains. Antibodies for Wnt 10b and nestin antibodies were obtained from Abcam (Cambridge, UK, ab91201 and ab105389, respectively). All steps were performed following the manufacturers’ instructions. Conjugated secondary antibodies were obtained from Thermo Fisher Scientific (Fremont, CA USA). Sections were imaged using a Nikon Eclipse 80i microscope (Tokyo, Japan).
This study was based on an initial sample size of 240 canals harvested and observed over 3 time intervals of 1, 3 and 6 months. There were some canals excluded from the study by selection criteria and others that were lost during processing. These values are shown in Table 1. The summative outcome of this study are described in Tables 1 and 2. Chi-Square test was used to compare the two proportions with significant differences set at p < 0.05 level.
In a previous work, we showed that nearly 85% of the RAP-treated group showed pulp regeneration, the rest did not show pulp regeneration and none of the CH-treated group showed pulp regeneration as well . Thus, a comparison of the nature of the remaining regenerated calcified tissues of the RAP-treated group that showed no pulp regeneration compared to the CH-treated group would be described below.
Calcium hydroxide-treated-canal cohort
The outcomes of calcium hydroxide treatment were more variable over the post-treatment time intervals. At 1-month post-treatment, only few samples showed histological evidence of complete apical bridging (Fig. 1a, Tables 1 and 2), whereas most of the treated canals had root apices that were either wholly open or showed signs of incomplete closure (Fig. 1b & c). Mild staining for Wnt10b was identified in the newly formed dentin at the opened root apex and in the granulation tissue that was at a distance from root apex (Fig. 1b). Mild to moderate staining for the intermediate filament stem/progenitor cell marker nestin was identified in the newly formed dentin at the root apex. Granulation tissue showed moderate immuno-reactivity and was found at a distance from the root apex (Fig. 1c).
At the 3-month interval, only few specimens of the canals showed complete root apex closure formed by cellular mineralized tissue (Fig. 2a, Tables 1 and 2). Most specimens showed incomplete root apex closure (Fig. 2c). No immune-reactivity was observed for Wnt10b either in the newly formed dentin or the granulation tissue (Fig. 2b). Mild staining for the intermediate filament stem/progenitor cell marker nestin was identified in the newly formed dentin and granulation tissue, while intense staining was observed in the odontoblast cell layer (Fig. 2c).
At 6-months post-treatment, two histological patterns were recognized. The first was comprised of a thin layer with either a histologically incomplete or complete apical bridge (Fig. 3a & b, Tables 1 and 2). Minor thickening of the lateral portions of the root was also observed. Newly formed cementum was observed with no attachments to the granulation tissue. Incomplete islands of regenerated bone were observed, which had no attachments to the apical portion of the tooth. Granulation tissue persisted until the 6-months post-operative period. In the second pattern, canals showed complete apical closure by a continuous layer of mineralized tissue with thickened lateral walls. Mineralized tissue was present inside the apical portion of the root canal. In addition, the newly formed cellular cementum was not attached to the granulation tissue, which was always found at a distance from the apical bridge (Fig. 3c).
Amelogenin-treated canal cohort
At one-month post-treatment, the canals treated with RAP showed the formation of dentin bridges, all of which were formed either by an incomplete or complete calcified tissue barrier (Fig. 1d & e, g, Tables 1 and 2). A consistent cellular response accompanying the apical closure was the appearance of a layer of cellular granulation tissue surrounding the root apex (Fig. 1d-f). The walls adjacent to the root apices appeared thickened due to the formation of newly formed dentin. Regenerated odontoblasts were found to be covering the newly formed dentin (Fig. 1d-e). Moderate to intense staining for Wnt10b was identified in the newly formed dentin at the root apex as well as among the odontoblast cell layer and in the granulation tissue (Fig. 1e). In addition, intense staining for nestin was recognized in the odontoblasts and in the condensed and regenerated cellular granulation tissue that completely surrounded the regenerating root apex (Fig. 1f).
At 3-months post-treatment, most of the amelogenin-treated teeth revealed complete root closure, as evidenced by a micro-anatomical analysis of the apical area, which showed cellular continuity and a dentin layer (Fig. 2d-f, Tables 1 and 2). Regeneration of the attachment apparatus was observed histologically in samples from this time interval (Fig. 2d). Wnt10b was recognized immunologically in the newly formed dentin and granulation tissue (Fig. 3e).
Mild to moderate to staining for nestin was recognized in the newly formed dentin bridge, and the granulation tissue (Fig. 2f).
At 6-months post-treatment with amelogenin, nearly all teeth showed histological evidence of the complete closure of the apical area by a thick layer of calcified tissue. A significantly higher percentage of amelogenin treated canals (70.9%) had a complete root closure in comparison to CH treated canals (10.8%) (p-value < 0.001) (Fig. 3d, Table 2). The presence of dentin-associated mineralized tissue was detected in a significantly higher percentage of roots treated with CH (43.3%) in comparison to none in roots treated with amelogenin (p-value< 0.001). The percentage of calcified islands were significantly higher in CH treated canals (23.3%) in comparison to amelogenin treated canals (5%) (P < 0.001). Dentin walls appeared to be thickened with newly formed dentine (Fig. 3d-i).
Moderate to intense staining for Wnt10b was recognized in the newly formed dentin and periodontal ligament (PDL) (Fig. 3e). Furthermore, intense staining to nestin was also recognized in these same structures (Fig. 3g).
An ideal endodontic treatment outcome for pulpal and periapical diseases is to reverse the destruction of local tissue and promote healing of apical periodontitis. In addition, in cases of immature teeth, promoting root development and restoring anatomical and physiological functions is warranted. Endodontic management of immature, non-vital, permanent teeth is a great challenge to dentists. The closure of the root apex is essential to achieve a complete, tridimensional sealing of the root canal system to prevent the entry of microorganisms or their products and increase the success of the endodontic treatment .
An immature tooth with an open apex is conventionally treated with apexification, requiring a long-term treatment with CH to induce the formation of an apical barrier. This long-term treatment weakens the root structure and exerts a cytotoxic effect on stem cells [4, 7]. Thus, one main cause of tooth loss following apexification is root fracture [17, 18]. Regenerative endodontics, is the extension of root canal therapy, it uses biologically based procedures to replace damaged tooth structures such as dentin, root structures and restore the apical seal. The optimal goal of regenerative endodontics is to regenerate the pulp tissue. The present study showed no pulp regeneration as revealed by absence of immuno-reactivity to nestin, which detects the neuronal derivatives of the neural crest that comprises the dental pulp [19, 20]. Treatment modalities will change in teeth with regenerated roots and regenerated pulps as compared to teeth with regenerated roots and no regenerated pulps. The RAP treated canals showed a calcified tissue barrier forming a natural obturation that sealed the empty root canal cavities from the periapical area. The lateral dentin wall and apex thickening lined by the newly formed odontoblasts resultes in strengthening of the canal’s lateral wall, which is one of the main disadvantages of apexification [21, 22], further studies must be conducted to investigate whether these teeth must be filled with a suitable canal filling material or left without filling for further lateral dentin deposition. Cellular destruction in the wound area that occurs as a result of infection of the root canal and periapical area, observed as bone destruction around the root apices, could be healed via amelogenin therapy .
No intra canal medicament was used when teeth were cleaned, irrigated, dried and closed for one week to emphasize the presence of infection, and how the recombinant protein can regenerate the lost tissue in the presence of infection. The granulation tissue observed in the early phases of wound healing surrounding the apical region of the healing roots in both treated groups showed nestin immuno-reactivity; however, this intensity was increased in the amelogenin group, especially at one month. The stem/progenitor cells of the apical papilla and all odontogenic ectomesenchymal cells have been shown to express the nestin neurogenic marker . This may indicate that this tissue can develop into apical-papilla stem cells (APSCs) [24, 25]. Wnt 10b-mediated activation of canonical Wnt signaling has been shown to regulate mesenchymal stem cell fate by promoting regeneration via local MSC/progenitor cell recruitment. LRAP induces cementum and bone formation in human stem cells through the activation of the Wnt signaling cascade . In our study, the apical root areas treated with RAP for 6 months showed moderate to intense immuno-reactivity to Wnt 10b in the newly formed cementum, periodontal ligament, and bone that constituted the newly formed attachment apparatus. This may indicate that the regenerative tissue products are, at least partly, mediated by the activation of canonical Wnt signaling pathway.
Yamuchi et al. reported two types of mineralized tissues being formed in the root canal space in experimental animals after undergoing tissue-engineering therapy: dentin-associated mineralized tissues (DAMTs) and bony islands (BIs) . In the present study, DAMTs and BIs were mainly observed in the CH group. The presence of DAMTs and BIs may complicate root canal filling, thus implicating the favor of using amelogenin as material of choice. At 6 months, the apices all canals that showed no pulp regeneration were completely closed. Although the root canal was empty, it still showed regular outlines and had relatively thick dentin, which was attached to newly formed bone by newly regenerated periodontal ligament fibers. This created a natural obturation that sealed the root canal cavity from the periapical area. As mentioned before, further studies must be conducted to investigate whether these teeth must be filled with a suitable canal filling material or left without filling for further lateral dentin deposition. If further studies were in favor of root canal filling, the histological results in this study support the use of root canal filling with a material capable of adapting to the canal anatomy, especially in the apical third of the canal.
Recombinant amelogenin shows great potential as an apexification agent alternative to traditional CH therapy. It provides an alternative technique for root canal filling, in which the regenerated calcified barrier can form a natural obturation, stimulating root growth and the regeneration of the dental attachment apparatus in non-vital, young, permanent teeth.
Dentin-associated mineralized tissue
Recombinant amelogenin protein
Witherspoon DE, Ham K. One-visit apexification: technique for inducing root-end barrier formation in apical closures. Pract Proced Aesthet Dent. 2001;13(6):455–60 quiz 62.
Rafter M. Apexification: a review. Dent Traumatol. 2005;21(1):1–8.
Murata SS, Holland R, Souza V, Dezan Junior E, Grossi JA, Percinoto C. Histological analysis of the periapical tissues of dog deciduous teeth after root canal filling with diferent materials. J Appl Oral Sci. 2005;13(3):318–24.
Dominguez Reyes A, Munoz Munoz L, Aznar Martin T. Study of calcium hydroxide apexification in 26 young permanent incisors. Dent Traumatol. 2005;21(3):141–5.
Shabahang S, Torabinejad M, Boyne PP, Abedi H, McMillan P. A comparative study of root-end induction using osteogenic protein-1, calcium hydroxide, and mineral trioxide aggregate in dogs. J Endod. 1999;25(1):1–5.
Andreasen JO, Munksgaard EC, Bakland LK. Comparison of fracture resistance in root canals of immature sheep teeth after filling with calcium hydroxide or MTA. Dent Traumatol. 2006;22(3):154–6.
Beslot-Neveu A, Bonte E, Baune B, Serreau R, Aissat F, Quinquis L, Grabar S, Lasfargues JJ. Mineral trioxyde aggregate versus calcium hydroxide in apexification of non vital immature teeth: study protocol for a randomized controlled trial. Trials. 2011;12:174.
Aoba T, Moreno EC, Kresak M, Tanabe T. Possible roles of partial sequences at N- and C-termini of amelogenin in protein-enamel mineral interaction. J Dent Res. 1989;68(9):1331–6.
Hamamoto Y, Nakajima T, Ozawa H, Uchida T. Production of amelogenin by enamel epithelium of Hertwig’s root sheath. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(6):703–9.
Hammarstrom L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol. 1997;24(9 Pt 2):669–77.
Warotayanont R, Zhu D, Snead ML, Zhou Y. Leucine-rich amelogenin peptide induces osteogenesis in mouse embryonic stem cells. Biochem Biophys Res Commun. 2008;367(1):1–6.
Boabaid F, Gibson CW, Kuehl MA, Berry JE, Snead ML, Nociti FH Jr, Katchburian E, Somerman MJ. Leucine-rich amelogenin peptide: a candidate signaling molecule during cementogenesis. J Periodontol. 2004;75(8):1126–36.
Stevens JR, Miranda-Carboni GA, Singer MA, Brugger SM, Lyons KM, Lane TF. Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J Bone Miner Res. 2010;25(10):2138–47.
Mounir MM, Matar MA, Lei Y, Snead ML. Recombinant Amelogenin protein induces apical closure and pulp regeneration in open-apex, nonvital permanent canine teeth. J Endod. 2016;42(3):402–12.
Felippe WT, Felippe MC, Rocha MJ. The effect of mineral trioxide aggregate on the apexification and periapical healing of teeth with incomplete root formation. Int Endod J. 2006;39(1):2–9.
Hargreaves KM, Giesler T, Henry M, Wang Y. Regeneration potential of the young permanent tooth: what does the future hold? J Endod. 2008;34(7 Suppl):S51–6.
Sonoyama W, Liu Y, Yamaza T, Tuan RS, Wang S, Shi S, Huang GT. Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod. 2008;34(2):166–71.
Stewart GG. Calcium hydroxide-induced root healing. Oral Health. 1975;65(12):10–5.
Vang H, Chung G, Kim HY, Park SB, Jung SJ, Kim JS, Oh SB. Neurochemical properties of dental primary afferent neurons. Exp Neurobiol. 2012;21(2):68–74.
Terling C, Rass A, Mitsiadis TA, Fried K, Lendahl U, Wroblewski J. Expression of the intermediate filament nestin during rodent tooth development. Int J Dev Biol. 1995;39(6):947–56.
Lin LM, Rosenberg PA. Repair and regeneration in endodontics. Int Endod J. 2011;44(10):889–906.
Lovelace TW, Henry MA, Hargreaves KM, Diogenes A. Evaluation of the delivery of mesenchymal stem cells into the root canal space of necrotic immature teeth after clinical regenerative endodontic procedure. J Endod. 2011;37(2):133–8.
Wen X, Cawthorn WP, MacDougald OA, Stupp SI, Snead ML, Zhou Y. The influence of leucine-rich amelogenin peptide on MSC fate by inducing Wnt10b expression. Biomaterials. 2011;32(27):6478–86.
Huang GT, Sonoyama W, Liu Y, Liu H, Wang S, Shi S. The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod. 2008;34(6):645–51.
Liao J, Al Shahrani M, Al-Habib M, Tanaka T, Huang GT. Cells isolated from inflamed periapical tissue express mesenchymal stem cell markers and are highly osteogenic. J Endod. 2011;37(9):1217–24.
Sarkar L, Sharpe PT. Expression of Wnt signalling pathway genes during tooth development. Mech Dev. 1999;85(1–2):197–200.
Yamauchi N, Yamauchi S, Nagaoka H, Duggan D, Zhong S, Lee SM, Teixeira FB, Yamauchi M. Tissue engineering strategies for immature teeth with apical periodontitis. J Endod. 2011;37(3):390–7.
We are grateful to Professor Malcolm L. Snead, University of Southern California, Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry of USC, Los Angeles, USA for providing the RAP and his support.
This work was supported by a grant from Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia, grant number (352/165/1433). The fund covers all materials used at the research project, laboratory technical work, statistical analysis, and minor compensation to the research team.
Availability of data and materials
This will be available in request.
The approval of the procedures was obtained from the ethics research committee in charged with the safety and protection of vertebrate animals, Pharos University, Alexandria, Egypt. The study was in full accordance with the National Institutes of Health; Guide for the care and use of laboratory animals.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mounir, M.M.F., Farsi, J.M.A., Alhazzazi, T.Y. et al. Characterization of the apical bridge barrier formed following amelogenin apexification. BMC Oral Health 18, 201 (2018). https://doi.org/10.1186/s12903-018-0641-0
- Recombinant amelogenin
- Root canal therapy
- Non-vital teeth
- Open apex
- Immature teeth